Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Routbort

Showing results (51-60 of 197) with videos related to

Pageof 20
Sort By:
Leukemia|August 1, 2015
IDH1 and IDH2 mutations in myelodysplastic syndromes and role in disease progressionC D DiNardo, E Jabbour, F Ravandi, et al.
The Journal of Molecular Diagnostics : JMD|February 24, 2019
A Model Information Management Plan for Molecular Pathology Sequence Data Using Standards: From Sequencer to Electronic Health RecordWalter S Campbell, Alexis B Carter, Allison M Cushman-Vokoun, et al.
JCO Precision Oncology|September 11, 2020
Germline Genetic Predisposition to Myeloid Neoplasia From <i>GATA2</i> Gene Mutations: Lessons Learned From Two CasesIman Abou Dalle, Sarah A Bannon, Keyur P Patel, et al.
American Journal of Hematology|August 11, 2019
Successful lenalidomide treatment in high risk myelodysplastic syndrome with germline DDX41 mutationIman Abou Dalle, Hagop Kantarjian, Sarah A Bannon, et al.
The Journal of Molecular Diagnostics : JMD|December 27, 2016
A Targeted High-Throughput Next-Generation Sequencing Panel for Clinical Screening of Mutations, Gene Amplifications, and Fusions in Solid TumorsRajyalakshmi Luthra, Keyur P Patel, Mark J Routbort, et al.
Discovery Medicine|February 19, 2014
Implementation of biomarker-driven cancer therapy: existing tools and remaining gapsAnn M Bailey, Yong Mao, Jia Zeng, et al.
The American Journal of Surgical Pathology|March 30, 2018
Chronic Myelomonocytic Leukemia With Fibrosis Is a Distinct Disease Subset With Myeloproliferative Features and Frequent JAK2 p.V617F MutationsHatice D Gur, Sanam Loghavi, Guillermo Garcia-Manero, et al.
The Journal of Molecular Diagnostics : JMD|October 16, 2022
Recommendations for the Use of in Silico Approaches for Next-Generation Sequencing Bioinformatic Pipeline Validation: A Joint Report of the Association for Molecular Pathology, Association for Pathology Informatics, and College of American PathologistsEric J Duncavage, Joshua F Coleman, Monica E de Baca, et al.
Cancer|September 2, 2011
Prognostic value of MYC rearrangement in cases of B-cell lymphoma, unclassifiable, with features intermediate between diffuse large B-cell lymphoma and Burkitt lymphomaPei Lin, Timothy J Dickason, Luis E Fayad, et al.
American Journal of Hematology|March 4, 2015
The clinical significance of negative flow cytometry immunophenotypic results in a morphologically scored positive bone marrow in patients following treatment for acute myeloid leukemiaJuan Ouyang, Maitrayee Goswami, Guilin Tang, et al.
Pageof 20

Showing results (51-60 of 197) with videos related to

Sort By:
Pageof 20
Leukemia|August 1, 2015
IDH1 and IDH2 mutations in myelodysplastic syndromes and role in disease progressionC D DiNardo, E Jabbour, F Ravandi, et al.
The Journal of Molecular Diagnostics : JMD|February 24, 2019
A Model Information Management Plan for Molecular Pathology Sequence Data Using Standards: From Sequencer to Electronic Health RecordWalter S Campbell, Alexis B Carter, Allison M Cushman-Vokoun, et al.
JCO Precision Oncology|September 11, 2020
Germline Genetic Predisposition to Myeloid Neoplasia From <i>GATA2</i> Gene Mutations: Lessons Learned From Two CasesIman Abou Dalle, Sarah A Bannon, Keyur P Patel, et al.
American Journal of Hematology|August 11, 2019
Successful lenalidomide treatment in high risk myelodysplastic syndrome with germline DDX41 mutationIman Abou Dalle, Hagop Kantarjian, Sarah A Bannon, et al.
The Journal of Molecular Diagnostics : JMD|December 27, 2016
A Targeted High-Throughput Next-Generation Sequencing Panel for Clinical Screening of Mutations, Gene Amplifications, and Fusions in Solid TumorsRajyalakshmi Luthra, Keyur P Patel, Mark J Routbort, et al.
Discovery Medicine|February 19, 2014
Implementation of biomarker-driven cancer therapy: existing tools and remaining gapsAnn M Bailey, Yong Mao, Jia Zeng, et al.
The American Journal of Surgical Pathology|March 30, 2018
Chronic Myelomonocytic Leukemia With Fibrosis Is a Distinct Disease Subset With Myeloproliferative Features and Frequent JAK2 p.V617F MutationsHatice D Gur, Sanam Loghavi, Guillermo Garcia-Manero, et al.
The Journal of Molecular Diagnostics : JMD|October 16, 2022
Recommendations for the Use of in Silico Approaches for Next-Generation Sequencing Bioinformatic Pipeline Validation: A Joint Report of the Association for Molecular Pathology, Association for Pathology Informatics, and College of American PathologistsEric J Duncavage, Joshua F Coleman, Monica E de Baca, et al.
Cancer|September 2, 2011
Prognostic value of MYC rearrangement in cases of B-cell lymphoma, unclassifiable, with features intermediate between diffuse large B-cell lymphoma and Burkitt lymphomaPei Lin, Timothy J Dickason, Luis E Fayad, et al.
American Journal of Hematology|March 4, 2015
The clinical significance of negative flow cytometry immunophenotypic results in a morphologically scored positive bone marrow in patients following treatment for acute myeloid leukemiaJuan Ouyang, Maitrayee Goswami, Guilin Tang, et al.
Pageof 20